DEF: Innovative Eyewear Seeks Shareholder Approval for Name Change to Lucyd, Inc. and Key Governance Proposals

Innovative Eyewear, Inc. is calling its stockholders to a virtual annual meeting on August 26, 2025, to vote on the election of directors, auditor ratification, a company name change to Lucyd, Inc., the extension of a shareholder rights plan, and the reinstatement of voting rights for certain control shares.

Summary

• The 2025 Annual Meeting of Stockholders for Innovative Eyewear, Inc. will be held virtually on Tuesday, August 26, 2025, at 10:00 a.m. Eastern Time.
• Stockholders will vote on the election of four directors: Harrison Gross, Kristen McLaughlin, Louis Castro, and Olivia C. Bartlett, to serve until the 2026 annual meeting.
• A proposal to ratify the appointment of Cherry Bekaert LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, will be presented.
• Shareholders will vote on the reinstatement of voting rights for 1,000,000 shares (approximately 22% of outstanding shares) held by Vladimir Galkin and Angelica Galkin, which were previously denied voting rights under Florida's Control-share acquisitions act.
• An amendment to the Articles of Incorporation to change the company's name to Lucyd, Inc. will be put to a vote.
• Stockholders will also vote to ratify an amendment to the rights plan, extending it for one year, until September 26, 2026.
• The Board unanimously recommends a vote FOR the election of all director nominees, and FOR Proposals 2 (auditor ratification), 4 (name change), and 5 (rights plan extension).
• The Board is not making a recommendation on Proposal 3, regarding the reinstatement of voting rights to certain control shares.
• As of the Record Date, June 30, 2025, there were 4,574,602 shares of Common Stock outstanding.
• The company incurred $140,000 in management service fees and $92,312 in rent expense to Tekcapital Europe Ltd. for the year ended December 31, 2024.

Sentiment

Score: 6

Explanation: The document is a standard proxy statement outlining routine annual meeting proposals, including a strategic name change and governance matters. While the control share issue and rights plan extension introduce elements of corporate control dynamics, the overall tone is procedural and compliant, with no explicit negative financial performance indicators. The board's non-recommendation on the control shares adds a neutral element to that specific proposal.

Positives

• The Board has nominated a slate of experienced directors, including individuals with substantial experience in the eyewear industry, public company directorships, and financial expertise.
• The company maintains a strong corporate governance structure with independent directors forming a majority on the Board and its key committees (Audit, Compensation, Nominating and Corporate Governance).
• Louis Castro, a director, has been identified as an audit committee financial expert, enhancing financial oversight.
• The company has a formal Code of Ethics in place for directors and principal executives, promoting ethical conduct.
• All Section 16(a) reports for directors and executive officers were timely filed in fiscal year 2024, indicating compliance with regulatory reporting requirements.
• The proposed name change to Lucyd, Inc. aims to clarify brand ownership and emphasize commitment to the core smartglasses product offering, which could enhance brand recognition and market alignment.
• The company successfully received repayment of a 600,000 British pounds sterling (approximately $768,000) loan to Tekcapital Europe Ltd. in 2024 and a $250,000 loan in June 2025, demonstrating effective management of intercompany financing.

Negatives

• The company faces a significant corporate governance issue regarding the 1,000,000 control shares (approximately 22% of outstanding shares) held by Vladimir and Angelica Galkin, whose voting rights are currently denied under Florida law.
• The Board has chosen not to make a recommendation on the proposal to reinstate voting rights to these control shares, which could signal internal division or a desire to avoid taking a stance on a potentially contentious issue.
• The extension of the shareholder rights plan (poison pill) suggests ongoing concerns about potential hostile takeovers or significant beneficial ownership acquisitions without Board approval, which could be perceived negatively by some investors as anti-shareholder.
• The company engages in multiple related party transactions, including a perpetual license agreement, management service agreements, and financing/loan agreements with Lucyd Ltd. and Tekcapital Europe Ltd., which, despite oversight, can raise questions about potential conflicts of interest.

Risks

• The denial of voting rights to 1,000,000 control shares (approximately 22% of outstanding shares) held by the Galkins under Florida's Control-share acquisitions act poses a risk of shareholder disputes or challenges to corporate control.
• The existence and proposed extension of the Rights Agreement (poison pill) indicate a perceived risk of unwanted acquisition or significant beneficial ownership, which could deter potential beneficial offers for the company.
• Activation of the Rights Agreement's 'Flip-In Trigger' could lead to substantial dilution for existing shareholders, excluding the Acquiring Person.
• Ongoing related party transactions with Lucyd Ltd. and Tekcapital Europe Ltd. (affiliates) carry inherent risks of conflicts of interest, even with stated review policies by the Audit Committee and independent directors.
• The Board's non-recommendation on the control share voting rights reinstatement could lead to uncertainty or a contentious vote outcome, potentially impacting investor confidence or corporate stability.

Future Outlook

The document outlines proposals for the upcoming annual meeting, including a strategic name change to Lucyd, Inc. to emphasize the company's primary product offering and brand identity. It also indicates a proactive stance on corporate control through the proposed extension of the shareholder rights plan. No specific financial guidance or forward-looking performance estimates are provided.

Management Comments

• The Board unanimously recommends a vote FOR the election of each of the director nominees, as well as a vote FOR each of Proposal 2, Proposal 4 and Proposal 5.
• The Board is not making a recommendation how the shareholder should vote on the reinstatement of voting rights to the Control Shares.
• The Company believes the name change will bring the following benefits: clarifying ownership of Lucyd brand marks, more clearly attributing 'Powered by Lucyd' cobranded product lines, emphasizing commitment to Lucyd smartglasses as the primary product offering, and improving alignment of the stock ticker and the company's core brand.

Industry Context

Innovative Eyewear operates in the smart eyewear industry. The proposed name change to Lucyd, Inc. signifies a strategic pivot or increased focus on its 'Lucyd' smartglasses brand, aligning the corporate identity more closely with its core product line. This move suggests a commitment to establishing a stronger brand presence in the competitive smart eyewear market.

Comparison to Industry Standards

• The company's corporate governance structure, with a majority of independent directors on the Board and key committees (Audit, Compensation, Nominating and Corporate Governance), aligns with best practices for publicly traded companies, similar to those observed in other technology or consumer electronics firms listed on NASDAQ.
• The appointment of an audit committee financial expert (Louis Castro) is a standard requirement and a positive indicator of robust financial oversight, comparable to governance standards in well-established public companies.
• The use of a shareholder rights plan (poison pill) is a defensive anti-takeover measure, which, while legal, can sometimes be viewed as deviating from shareholder-friendly governance by limiting potential acquisition premiums. Its extension suggests the company perceives ongoing control risks, a common consideration for smaller public companies in growth industries.
• The related party transactions, particularly the licensing agreement and management services with entities linked to the company's founders and major shareholders (Lucyd Ltd., Tekcapital Europe Ltd.), are common in early-stage or closely-held public companies but require stringent oversight to meet industry standards for arm's-length dealings, which the company states it addresses through Audit Committee review.

Management Changes

Corporate Governance

Related Party Transactions

• Exclusive, worldwide, royalty-free, fully paid-up, and perpetual license agreement with Lucyd Ltd. (a significant stockholder) for the Lucyd brand and associated intellectual property, effective April 1, 2020. Innovative Eyewear issued 187,500 post-reverse-split shares as compensation.
• Management service agreement with Tekcapital Europe Ltd. (an affiliate of Lucyd Ltd., and whose CEO is the father of Innovative Eyewear's CEO), under which Innovative Eyewear paid $140,000 for advisory and other services and recognized $92,312 in allocated rent expense for the year ended December 31, 2024.
• New financing agreement with Lucyd Ltd. (effective March 1, 2024) allowing Innovative Eyewear to receive up to $1,250,000 in services or cash, in exchange for a 10% convertible note maturing September 1, 2026. No amounts have been borrowed yet.
• Intercompany loan agreement (January 11, 2024) with Tekcapital Europe Ltd. for 600,000 British pounds sterling (approximately $768,000) at 10% interest, which was fully repaid by December 31, 2024.
• New intercompany loan facility (April 23, 2025) with Tekcapital Europe Ltd. for up to $500,000 at 10% interest, with $250,000 borrowed and repaid in May/June 2025.

Stakeholder Impact

• Shareholders: Will directly influence corporate governance and strategic direction through their votes on director elections, auditor ratification, the company name change, the extension of the rights plan, and the critical decision regarding the reinstatement of voting rights for a significant control shareholder. The outcome of the control share vote could significantly alter the distribution of voting power.
• Employees: Executive compensation details are disclosed, and full-time W-2 employees receive health insurance, free prescription eyeglasses, and complimentary gym memberships, indicating benefits and compensation practices.
• Customers: The proposed name change to Lucyd, Inc. is intended to clarify brand ownership and emphasize the company's commitment to its Lucyd smartglasses, potentially enhancing brand recognition and product focus for customers.
• Suppliers/Creditors: The company's ongoing financing agreements and loan facilities with related parties (Lucyd Ltd., Tekcapital Europe Ltd.) indicate its financial relationships and potential sources of capital, which are relevant to its ability to meet obligations.

Next Steps

• Stockholders are requested to read the Proxy Statement and promptly vote their proxy via the internet, telephone, or mail to assure representation at the Annual Meeting.
• The Annual Meeting of Stockholders will be held virtually on August 26, 2025, at 10:00 a.m. Eastern Time.
• If Proposal 4 (Name Amendment) is approved, the name change to Lucyd, Inc. will become immediately effective upon its filing with the office of the Florida Secretary of State.
• Voting results of the Annual Meeting may be announced at the meeting and subsequently filed in a Current Report on Form 8-K.
• The elected directors will hold office until the company's 2026 annual meeting of stockholders.

Key Dates

Recommendation

Keywords

Innovative Eyewear, Lucyd, Proxy Statement, Annual Meeting, Corporate Governance, Director Election, Name Change, Control Shares, Voting Rights, Shareholder Rights Plan, SEC Filing, Smart Eyewear, Auditor Ratification, Related Party Transactions